住院儿科患者AKI轨迹:持续时间与重复事件的影响
AKI发生率为5.6%,重复AKI事件占1.92%。AKI与死亡率相关(OR 6.0,95%CI 4.8-7.6;P<0.001),最大KDIGO分期与死亡率关联最强,重复事件和AKI持续时间也与死亡率相关。
要点
- 住院儿科患者AKI发生率为5.6%,重复AKI事件占1.92%。
- AKI与死亡率独立相关(OR 6.0,95%CI 4.8-7.6;P<0.001)。
- 最大KDIGO分期与死亡率关联最强,重复事件和持续时间也需考虑。
核心结论
- 住院儿科患者AKI发生率为5.6%,重复AKI事件约占30%。
- 最大KDIGO分期与死亡率关联最强,重复AKI事件和AKI持续时间也应纳入预后评估。
研究设计与样本
- 排除维持性肾脏替代治疗患者,至少一次血清肌酐检测,按KDIGO标准分期。
主要发现
- 重复AKI事件发生于1.92%(n=3558)的住院例次。
- AKI与死亡率相关(OR 6.0,95%CI 4.8-7.6;P<0.001),KDIGO最大分期增加与死亡率升高相关。
- 重复AKI事件与死亡率相关(P<0.001),AKI持续时间与死亡率相关(P<0.001),AKI速度与死亡率无关(P>0.05)。
关键数值与推荐
- AKI分期采用KDIGO标准,基于7天内血清肌酐较最低值的百分比变化。
- 重复AKI事件定义为KDIGO标准满足超过一次,且两次事件间至少一次血清肌酐未达KDIGO标准。
临床怎么用
- 在评估住院儿科患者预后时,除AKI最大分期外,应关注重复AKI事件和AKI持续时间。
- AKI速度与死亡率无关,提示临床关注重点应为AKI严重程度、持续时间和复发。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Peak severity of acute kidney injury (AKI) is associated with mortality in hospitalized pediatric patients. Other factors associated with AKI, such as number of AKI events, severity of AKI events and time spent in AKI, may also have associations with mortality. Characterization of these events could help to evaluate patient outcomes. METHODS: Pediatric inpatients (<19 years of age) from 2011 to 2019 who were not on maintenance renal replacement therapy and had least one serum creatinine (SCr) obtained during hospital admission were included. Percent change in SCr from the minimum value in the prior 7 days was used for AKI staging according to Kidney Disease: Improving Global Outcomes (KDIGO) criteria. Maximum value for age appropriate normal was used for patients with only one SCr. Repeat AKI events were classified in patients if KDIGO criteria were met more than once with at least one SCr value between episodes that did not meet KDIGO criteria. Patient demographics were summarized and incidence of AKI was determined along with associations with mortality. AKI characterizations for the admission were developed including: AKI, repeat (more than one) AKI, AKI severity (maximum KDIGO stage) and total number of AKI events. AKI duration as percent admission days in a KDIGO stage and AKI percent velocity were determined. Kaplan-Meier analysis was performed for time to 30-day survival by AKI characterization. A mixed-effects logistic regression model with mortality as the dependent variable nested in patients was developed incorporating patient variables and AKI characterizations. RESULTS: A total of 184 297 inpatient encounters met study criteria [male 51.7%, age 7.8 years (interquartile range 2.5-13.8) and mortality 0.56%]. Hospital length of stay was 1.9 days (IQR 0.37, 4.8 days), 15.4% had an intensive care unit admission and 12.2% underwent mechanical ventilation. AKI occurred in 5.6% (n = 10 246) of admissions [Stage 1, 4.5% (n = 8310); Stage 2, 1.3% (n = 2363); Stage 3, 0.77% (n = 1423)] and repeat AKI events occurred in 1.92% (n = 3558). AKI was associated with mortality (odds ratio 6.0, 95% confidence interval 4.8-7.6; P < 0.001) and increasing severity (KDIGO maximum stage) was associated with increased mortality. Multiple AKI events were also associated with mortality (P < 0.001). Duration of AKI was associated with mortality (P < 0.001) but AKI velocity was not (P > 0.05). CONCLUSIONS: AKI occurs in 5.6% of the pediatric inpatient population and multiple AKI events occur in ∼30% of these patients. Maximum KDIGO stage is most strongly associated with mortality. Multiple AKI events and AKI duration should also be considered when evaluating patient outcomes.
引用
- Moffett BS, Arikan AA. Trajectory of AKI in hospitalized pediatric patients-impact of duration and repeat events. Nephrol Dial Transplant. 2022. PMID: 34245299. doi:10.1093/ndt/gfab219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。